Company Innovotech Inc Toronto S.E.

Equities

IOT

CA45772U1049

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.

CAD in Million	2022	Weight	2023	Weight	Delta
Contract Research Fees 80.8 %	1	79.1 %	1	80.8 %	+7.27%
Seed Treatment 19.2 %	0	19.5 %	0	19.2 %	+3.80%

CAD in Million	2022	Weight	2023	Weight	Delta
United States 87.5 %	1	85.1 %	1	87.5 %	+8.10%
Rest of World 10.7 %	0	12.1 %	0	10.7 %	-7.05%
Canada 1.7 %	0	2.8 %	0	1.7 %	-35.10%

Managers	Title	Age	Since
Craig Milne CEO	Chief Executive Officer	-	18/07/19
Bernard Grobbelaar DFI	Director of Finance/CFO	-	29/04/13
James Timourian CHM	Chairman	-	21/10/02
Patricia Nadworny CTO	Chief Tech/Sci/R&D Officer	-	31/12/09
Tyler Boone COO	Chief Operating Officer	-	31/12/16

Members of the board	Title	Age	Since
Karen L. Farkas BRD	Director/Board Member	-	14/12/19
James Timourian CHM	Chairman	-	21/10/02
Bernard Grobbelaar DFI	Director of Finance/CFO	-	29/04/13
Craig Milne CEO	Chief Executive Officer	-	18/07/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	39,003,612	22,282,057 ( 57.13 %)	0	57.13 %

Name	Equities	%	Valuation
Alan Savage 35.21 %	13,734,555	35.21 %	1 M $
James Timourian 5.443 %	2,123,000	5.443 %	178 332 $
Shong Tak Tam 1.669 %	651,000	1.669 %	54 684 $
Craig Milne 0.7538 %	294,000	0.7538 %	24 696 $
Tyler Boone 0.2797 %	109,112	0.2797 %	9 165 $
Bernard Grobbelaar 0.0897 %	35,000	0.0897 %	2 940 $
Karen L. Farkas 0.0385 %	15,000	0.0385 %	1 260 $
Patricia Nadworny 0.000000 %	0	0.000000 %	- $
Julienne Wright 0.000000 %	0	0.000000 %	- $

Innovotech, Inc.

2011-94th Street Suite L131

T6N 1H1, Edmonton

http://www.innovotech.ca

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+24.74%	47.96B
IQVIA HOLDINGS INC.	-0.47%	42.45B
LONZA GROUP AG	+43.96%	41.47B
ALNYLAM PHARMACEUTICALS, INC.	+25.40%	31.6B
ICON PUBLIC LIMITED COMPANY	+17.96%	28.63B
CELLTRION, INC.	-4.47%	28.03B
UNITED THERAPEUTICS CORPORATION	+50.73%	14.56B
MEDPACE HOLDINGS, INC.	+42.56%	14.14B
BIO-TECHNE CORPORATION	+1.46%	12.58B

Other Biotechnology & Medical Research